Review Article

Prevalence of Posttraumatic Stress Disorder among Breast Cancer Patients: A Meta-analysis

Abstract

Background: Prevalence estimates of Posttraumatic Stress Disorder (PTSD) among breast cancer patients varied widely in existing studies. This study aimed to provide an overall prevalence estimate of PTSD among breast cancer patients, and the prevalence estimates related to specific PTSD diagnosis tools.

Methods: Systematic search of relevant articles was made from seven databases. Freeman-Tukey Double Arcsine Transformation was used to estimate the overall prevalence of PTSD. Sub-group and meta-regression analyses were used to investigate the between-study sources of heterogeneity. Publication bias was examined using Egger’s funnel plot and Begg test.

Results: The pooled prevalence of PTSD among breast cancer patients was [9.6%, 95% confidence intervals (95%CI)=7.9-11.5%]. Studies that used Clinician Administered PTSD Scale-Form (CAPS) method alone yielded much higher prevalence (19.0%, 95%CI=13.1-25.5%, n=5) than three or fourth edition Structured Clinical Interview for Diagnostic and Statistical Manual (SCID) method alone (3.0%, 95%CI= 2.2-3.9%, n=11). Prevalence estimates for studies that used the methods: PTSD Checklist—Civilian Version (PCL-C) cut-off, PCL-C cluster, and Impact of Event Scale (IES) cut-off were (7.0%, 95%CI= 3.9-10.8%, n=10), (11.5%, 95%CI= 8.6-15.6%, n=11) and (15.1%, 95%CI= 12.3-18.2%, n=4), respectively. Heterogeneity between-study was substantial (I2=44.9–92.3%).

Conclusion: About 9.6% of the breast cancer patients would develop the PTSD symptoms. Those who were younger, non-Caucasian and recently completed treatment would be at a greater risk of developing PTSD.

 

Association AP (1994). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. ed., American Psychiatric Association. Washington, DC.

Heim C, Nemeroff CB (2009). Neurobiology of posttraumatic stress disorder. CNS Spectr, 14(1 Suppl 1):13-24.

Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJL, Naghavi M (2011). Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet, 378:1461-1484.

Vahdaninia M, Omidvari S, Montazeri A (2010). What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol, 45:355-61.

Kangas M, Henry JL, Bryant RA (2002). Posttraumatic stress disorder following cancer. A conceptual and empirical review. Clin Psychol Rev, 22:499-524.

Mundy EA, Blanchard EB, Cirenza E, Gargiulo J, Maloy B, Blanchard CG (2000). Posttraumatic stress disorder in breast cancer patients following autologous bone marrow transplantation or conventional cancer treatments. Behav Res Ther, 38:1015-27.

Naidich JB, Motta RW (2000). PTSD-Related Symptoms in Women with Breast Cancer. J Psychother Independent Practice, 1:35-54.

Cordova MJ, Andrykowski MA, Kenady DE, McGrath PC, Sloan DA, Redd WH (1995). Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. J Consult Clin Psychol, 63:981-6.

Andrykowski MA, Cordova MJ, McGrath PC, Sloan DA, Kenady DE (2000). Stability and change in posttraumatic stress disorder symptoms following breast cancer treatment: a 1-year follow-up. Psychooncology, 9:69-78.

Cordova MJ, Studts JL, Hann DM, Jacobsen PB, Andrykowski MA (2000). Symptom structure of PTSD following breast cancer. J Trauma Stress, 13:301-19.

Kornblith AB, Herndon JE, 2nd, Weiss RB, Zhang C, Zuckerman EL, Rosenberg S, Mertz M, Payne D, Jane Massie M, Holland JF, Wingate P, Norton L, Holland JC (2003). Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer, 98:679-89.

O'Connor M, Christensen S, Jensen AB, Moller S, Zachariae R (2011). How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer. Br J Cancer, 104:419-26.

Vin-Raviv N, Hillyer GC, Hershman DL, Galea S, Leoce N, Bovbjerg DH, Kushi LH, Kroenke C, Lamerato L, Ambrosone CB, Valdimorsdottir H, Jandorf L, Mandelblatt JS, Tsai WY, Neugut AI (2013). Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. J Natl Cancer Inst, 105:563-72.

Andrykowski MA, Cordova MJ, Studts JL, Miller TW (1998). Posttraumatic stress disorder after treatment for breast cancer: prevalence of diagnosis and use of the PTSD Checklist-Civilian Version (PCL-C) as a screening instrument. J Consult Clin Psychol, 66:586-90.

Abbey G, Thompson SB, Hickish T, Heathcote D (2015). A meta-analysis of prevalence rates and moderating factors for cancer-related post-traumatic stress disorder. Psychooncology, 24:371-81.

First MB, Spitzer RL, Gibbon M, Williams, JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP). ed., New York: Biometrics Research, New York State Psychiatric Institute.

Weathers FW LB, Herman DS, Huska JA, Keane TM (1991). The PTSD Checklist—Civilian Version (PCL-C). ed., Available from F.W. Weathers, National Center for PTSD, Boston Veterans Affairs Medical Center, 150 S. Huntington Avenue, Boston, MA, 02130.

Loney PL, Chambers LW, Bennett KJ, Roberts JG, Stratford PW (1998). Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can, 19:170-6.

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327:557-60.

Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315:629.

Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50:1088-101.

Green BL, Rowland JH, Krupnick JL, Epstein SA, Stockton P, Stern NM, Spertus IL, Steakley C (1998). Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics, 39:102-11.

Jacobsen PBP, Widows MRBS, Hann DMP, Andrykowski MAP, Kronish LEBSN, Fields KKMD (1998). Posttraumatic Stress Disorder Symptoms After Bone Marrow Transplantation for Breast Cancer. [Article]. Psychosom Med, 60:366-371.

Tjemsland L, Soreide JA, Malt UF (1998). Posttraumatic distress symptoms in operable breast cancer III: status one year after surgery. Breast Cancer Res Treat, 47:141-51.

Pitman RK, Lanes DM, Williston SK, Guillaume JL, Metzger LJ, Gehr GM, Orr SP (2001). Psychophysiologic assessment of posttraumatic stress disorder in breast cancer patients. Psychosomatics, 42:133-40.

Amir M, Ramati A (2002). Post-traumatic symptoms, emotional distress and quality of life in long-term survivors of breast cancer: a preliminary research. J Anxiety Disord, 16:195-206.

Boyer BA, Bubel D, Jacobs SR, Knolls ML, Harwell VD, Goscicka M, Keegan A (2002). Post-traumatic stress in women with breast cancer and their daughters. Am J Fam Ther, 30:323-338.

Koopman C, Butler LD, Classen C, Giese-Davis J, Morrow GR, Westendorf J, Banerjee T, Spiegel D (2002). Traumatic stress symptoms among women with recently diagnosed primary breast cancer. J Trauma Stress, 15:277-87.

Luecken LJ, Dausch B, Gulla V, Hong R, Compas BE (2004). Alterations in morning cortisol associated with PTSD in women with breast cancer. J Psychosom Res, 56:13-5.

Palmer SCP, Kagee AP, Coyne JCP, DeMichele AMDM (2004). Experience of Trauma, Distress, and Posttraumatic Stress Disorder Among Breast Cancer Patients. [Article]. Psychosom Med, 66:258-264.

Levine EG, Eckhardt J, Targ E (2005). Change in post-traumatic stress symptoms following psychosocial treatment for breast cancer. Psychooncology, 14:618-35.

Matsuoka Y, Inagaki M, Sugawara Y, Imoto S, Akechi T, Uchitomi Y (2005). Biomedical and psychosocial determinants of intrusive recollections in breast cancer survivors. Psychosomatics, 46:203-11.

Shelby RA, Golden-Kreutz DM, Andersen BL (2005). Mismatch of posttraumatic stress disorder (PTSD) symptoms and DSM-IV symptom clusters in a cancer sample: exploratory factor analysis of the PTSD Checklist-Civilian Version. J Trauma Stress, 18:347-57.

Hegel MT, Moore CP, Collins ED, Kearing S, Gillock KL, Riggs RL, Clay KF, Ahles TA (2006). Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer, 107:2924-31.

Cordova MJ, Giese-Davis J, Golant M, Kronenwetter C, Chang V, Spiegel D (2007). Breast cancer as trauma: Posttraumatic stress and posttraumatic growth. J Clin Psychol Med Settings, 14:308-319.

Mehnert A, Koch U (2007). Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Psychooncology, 16:181-8.

Mehnert A, Koch U (2008). Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosom Res, 64:383-91.

Morrill EF, Brewer NT, O'Neill SC, Lillie SE, Dees EC, Carey LA, Rimer BK (2008). The interaction of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms and quality of life. Psychooncology, 17:948-53.

Shelby RA, Golden-Kreutz DM, Andersen BL (2008). PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors. J Trauma Stress, 21:165-72.

Gandubert C, Carriere I, Escot C, Soulier M, Hermes A, Boulet P, Ritchie K, Chaudieu I (2009). Onset and relapse of psychiatric disorders following early breast cancer: a case-control study. Psychooncology, 18:1029-37.

Elklit A, Blum A (2011). Psychological adjustment one year after the diagnosis of breast cancer: a prototype study of delayed post-traumatic stress disorder. Br J Clin Psychol, 50:350-63.

Kwakkenbos L, Coyne JC, Thombs BD (2014). Prevalence of posttraumatic stress disorder (PTSD) in women with breast cancer. J Psychosom Res, 76:485-6.

Yan LF (2010) Prevalence and influencing factors for PTSD in patients with cancer in hospital. D. Tongji Medical College Huazhong University of Science and Technology, China.

Liu B, Qiu JX, Pan M, JX C (2011). Post-traumatic Stress Disorders and the Risk factors in Cancer Patients. Shandong Medical, 51:83-84.

Pan W (2013). A correlative study of clinical psychological characteristics and heart rate variability in patients with cancer-related posttraumatic stress disorders. D. Affiliated First People's Hospital, Soochow University, China.

Okamura M, Yamawaki S, Akechi T, Taniguchi K, Uchitomi Y (2005). Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life. Jpn J Clin Oncol, 35:302-9.

Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM (1995). The development of a Clinician-Administered PTSD Scale. J Trauma Stress, 8:75-90.

Horowitz M, Wilner N, Alvarez W (1979). Impact of Event Scale: a measure of subjective stress. Psychosom Med, 41:209-18.

Alter CL, Pelcovitz D, Axelrod A, Goldenberg B, Harris H, Meyers B, Grobois B, Mandel F, Septimus A, Kaplan S (1996). Identification of PTSD in cancer survivors. Psychosomatics, 37:137-43.

Andrykowski MA, Cordova MJ (1998). Factors associated with PTSD symptoms following treatment for breast cancer: test of the Andersen model. J Trauma Stress, 11:189-203.

Pace TW, Heim CM (2011). A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav Immun, 25:6-13.

Association AP (2013). Diagnostic and Statistical Manual of Mental Disorders, (DSM-5). ed., American Psychiatric Association. Washington, DC.

Files
IssueVol 45 No 12 (2016) QRcode
SectionReview Article(s)
Keywords
Posttraumatic stress disorder Breast cancer Prevalence Meta-analysis

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
WU X, WANG J, COFIE R, C KAMINGA A, LIU A. Prevalence of Posttraumatic Stress Disorder among Breast Cancer Patients: A Meta-analysis. Iran J Public Health. 2016;45(12):1533-1544.